Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Estrogen plus Progestin and the Risk of Coronary Heart Disease

2003; Massachusetts Medical Society; Volume: 349; Issue: 6 Linguagem: Inglês

10.1056/nejmoa030808

ISSN

1533-4406

Autores

JoAnn E. Manson, Judith Hsia, Karen Johnson, Jacques E. Rossouw, Annlouise R. Assaf, Norman L. Lasser, Maurizio Trevisan, Henry R. Black, Susan R. Heckbert, Robert Detrano, Ora L. Strickland, Nathan D. Wong, John R. Crouse, Evan A. Stein, Mary Cushman,

Tópico(s)

Sex and Gender in Healthcare

Resumo

Recent randomized clinical trials have suggested that estrogen plus progestin does not confer cardiac protection and may increase the risk of coronary heart disease (CHD). In this report, we provide the final results with regard to estrogen plus progestin and CHD from the Women's Health Initiative (WHI).

Referência(s)